Jonathan C Javitt Nrx Pharmaceuticals, Inc. (NRXP) insider trading activity

NRXP Quotes by TradingView

Jonathan C Javitt is Chairman and Chief Scientist of NRX Pharmaceuticals, Inc.. Currently has a direct ownership of 84,634 shares of NRXP, which is worth approximately $127,797. The most recent transaction as insider was on Dec 17, 2024, when has been sold 40,000 shares (Common Stock) at a price of $1.17 per share, resulting in proceeds of $46,800. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 84.6K
81.04% 3M change
81.04% 12M change
Total Value Held $127,797

Jonathan C Javitt Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 17 2024
BUY
Open market or private purchase
$46,800 $1.17 p/Share
40,000 Added 32.09%
84,634 Common Stock
Aug 23 2023
BUY
Open market or private purchase
$33,000 $0.33 p/Share
100,000 Added 18.3%
446,332 Common Stock
Aug 22 2023
BUY
Open market or private purchase
$64,000 $0.32 p/Share
200,000 Added 36.61%
346,332 Common Stock
Jun 01 2022
BUY
Open market or private purchase
$5,800,000 $58.0 p/Share
100,000 Added 40.6%
146,332 Common Stock
May 24 2021
BUY
Grant, award, or other acquisition
-
46,332 Added 50.0%
46,332 Common Stock
JCJ

Jonathan C Javitt

Chairman and Chief Scientist
Wilmington, DE

Track Institutional and Insider Activities on NRXP

Follow NRX Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NRXP shares.

Notify only if

Insider Trading

Get notified when an Nrx Pharmaceuticals, Inc. insider buys or sells NRXP shares.

Notify only if

News

Receive news related to NRX Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on NRXP